Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Unlock The Hidden Results With Your Benzinga Account Now.
Inhibrx Biosciences Stock (NASDAQ: INBX) stock price, news, charts, stock research, profile.
You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.
Other companies in Inhibrx Biosciences’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL) and Larimar Therapeutics (NASDAQ:LRMR).
Inhibrx Biosciences has a consensus price target of $45.25.
The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $12.8 last updated February 20, 2025 at 4:00 PM EST.
There are no upcoming dividends for Inhibrx Biosciences.
Inhibrx Biosciences’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Inhibrx Biosciences.
Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.